Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Supernus Pharmaceuticals, Inc. Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy May 23, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures May 09, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces First Quarter 2024 Financial Results May 08, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story May 01, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 April 24, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Provides Regulatory Update for SPN-830 April 08, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Participate in Two Upcoming Investor Conferences March 06, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference February 28, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024 February 13, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent February 05, 2024 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces Third Quarter 2023 Financial Results November 08, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Participate in the Jefferies London Healthcare Conference November 07, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA November 02, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023 October 25, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey October 16, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device October 09, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held on October 18, 2023 in New York City September 27, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces New Qelbree® Data Showing Improvement in ADHD Symptoms September 09, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Participate in the Wells Fargo Healthcare Conference August 31, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Bethany L. Sensenig Joins Supernus’ Board of Directors August 21, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces Second Quarter 2023 Financial Results August 08, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 8, 2023 July 24, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Participate in the Jefferies Healthcare Conference May 31, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces First Quarter 2023 Financial Results May 09, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Present at the Bank of America 2023 Health Care Conference May 02, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Pharmaceuticals to Announce First Quarter 2023 Financial Results and Host Conference Call on May 9, 2023 April 25, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus Announces Repayment of Convertible Notes April 03, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Participate in Two Upcoming Investor Conferences March 08, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Supernus to Present at the Cowen 43rd Annual Health Care Conference March 01, 2023 From Supernus Pharmaceuticals, Inc. Via GlobeNewswire Tickers SUPN Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.